Loading clinical trials...
Loading clinical trials...
Open-Label, Multi-Center, Randomized, Active-Controlled, Phase 4 Study of rAd-p53 Gene Therapy Combined With Chemotherapy and Radiotherapy in Treament of Head and Neck Cancer in Advanced Stage
Conditions
Interventions
chemotherapy plus p53
chemotherapy
+1 more
Locations
1
China
Department of oral and maxillofacial surgery, Huaxi university of medical science
Chendu, Shichuan, China
Start Date
May 1, 2009
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2013
Last Updated
April 9, 2012
NCT00026884
NCT07159659
NCT07213804
NCT07169851
NCT07191730
NCT06662786
Lead Sponsor
Shenzhen SiBiono GeneTech Co.,Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions